Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$45.3 - $60.27 $298,980 - $397,782
-6,600 Closed
0 $0
Q3 2020

Nov 02, 2020

BUY
$47.45 - $62.95 $152,314 - $202,069
3,210 Added 94.69%
6,600 $313,000
Q2 2020

Aug 05, 2020

BUY
$46.85 - $61.05 $158,821 - $206,959
3,390 New
3,390 $200,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.67B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Asahi Life Asset Management Co., Ltd. Portfolio

Follow Asahi Life Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asahi Life Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asahi Life Asset Management Co., Ltd. with notifications on news.